180 Life Sciences Corp (ATNF)

3.51 +0.08 (+2.33%) USD  |  NASDAQ  |  Nov 05, 11:24
More

180 Life Sciences Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for ATNF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2021. Upgrade now.
Date Value
February 14, 2023 --
December 31, 2022 --
October 21, 2022 --
August 10, 2022 --
Date Value
May 09, 2022 --
February 02, 2022 --
December 31, 2021 --
September 15, 2021 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

--
Minimum
Sep 15 2021
Upgrade
Maximum
Feb 14 2023
Upgrade
Average
--
Median
Sep 15 2021

Revenue Estimates for Current Fiscal Year Benchmarks

Seelos Therapeutics Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade
iBio Inc Upgrade
Theriva Biologics Inc Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade